BACKGROUND: The role of polyphenol intake on cardiovascular risk factors is little explored, particularly in people with diabetes. AIM: To evaluate the association between the intake of total polyphenols and polyphenol classes with the major cardiovascular risk factors in a population with type 2 diabetes. METHODS: Dietary habits were investigated in 2573 males and females participants of the TOSCA.IT study. The European Prospective Investigation on Cancer and Nutrition (EPIC) questionnaire was used to assess dietary habits. In all participants, among others, we assessed anthropometry, plasma lipids, blood pressure, C-reactive protein and HbA1c following a standard protocol. The USDA and Phenol-Explorer databases were used to estimate the polyphenol content of the habitual diet. RESULTS: Average intake of polyphenols was 683.3 ± 5.8 mg/day. Flavonoids and phenolic acids were the predominant classes (47.5% and 47.4%, respectively). After adjusting for potential confounders, people with the highest intake of energy-adjusted polyphenols (upper tertile) had a more favorable cardiovascular risk factors profile as compared to people with the lowest intake (lower tertile) (BMI was 30.7 vs 29.9 kg/m2, HDL-cholesterol was 45.1 vs 46.9 mg/dl, LDL-cholesterol was 103.2 vs 102.1 mg/dl, triglycerides were 153.4 vs 148.0 mg/dl, systolic and diastolic blood pressure were respectively 135.3 vs 134.3 and 80.5 vs 79.6 mm/Hg, HbA1c was 7.70 vs 7.67%, and C-reactive Protein was 1.29 vs 1.25 mg/dl, p < .001 for all). The findings were very similar when the analysis was conducted separately for flavonoids or phenolic acids, the two main classes of polyphenols consumed in this population. CONCLUSIONS: Polyphenol intake is associated with a more favorable cardiovascular risk factors profile, independent of major confounders. These findings support the consumption of foods and beverages rich in different classes of polyphenols particularly in people with diabetes. CLINICAL TRIAL: http://www.clinicaltrials.gov; Study ID number: NCT00700856.

Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study / Vitale, Marilena; Vaccaro, Olga; Masulli, Maria; Bonora, Enzo; Del Prato, Stefano; Giorda, Carlo B.; Nicolucci, Antonio; Squatrito, Sebastiano; Auciello, Stefania; Babini, Anna C.; Bani, Laura; Buzzetti, Raffaella; Cannarsa, Emanuela; Cignarelli, Mauro; Cigolini, Massimo; Clemente, Gennaro; Cocozza, Sara; Corsi, Laura; D'Angelo, Federica; Dall'Aglio, Elisabetta; Di Cianni, Graziano; Fontana, Lucia; Gregori, Giovanna; Grioni, Sara; Giordano, Carla; Iannarelli, Rossella; Iovine, Ciro; Lapolla, Annunziata; Lauro, Davide; Laviola, Luigi; Mazzucchelli, Chiara; Signorini, Stefano; Tonutti, Laura; Trevisan, Roberto; Zamboni, Chiara; Riccardi, Gabriele; Rivellese, Angela A.. - In: CLINICAL NUTRITION. - ISSN 0261-5614. - 36:6(2017), pp. 1686-1692. [10.1016/j.clnu.2016.11.002]

Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study

Buzzetti, Raffaella
;
Iovine, Ciro;Signorini, Stefano;Riccardi, Gabriele;
2017

Abstract

BACKGROUND: The role of polyphenol intake on cardiovascular risk factors is little explored, particularly in people with diabetes. AIM: To evaluate the association between the intake of total polyphenols and polyphenol classes with the major cardiovascular risk factors in a population with type 2 diabetes. METHODS: Dietary habits were investigated in 2573 males and females participants of the TOSCA.IT study. The European Prospective Investigation on Cancer and Nutrition (EPIC) questionnaire was used to assess dietary habits. In all participants, among others, we assessed anthropometry, plasma lipids, blood pressure, C-reactive protein and HbA1c following a standard protocol. The USDA and Phenol-Explorer databases were used to estimate the polyphenol content of the habitual diet. RESULTS: Average intake of polyphenols was 683.3 ± 5.8 mg/day. Flavonoids and phenolic acids were the predominant classes (47.5% and 47.4%, respectively). After adjusting for potential confounders, people with the highest intake of energy-adjusted polyphenols (upper tertile) had a more favorable cardiovascular risk factors profile as compared to people with the lowest intake (lower tertile) (BMI was 30.7 vs 29.9 kg/m2, HDL-cholesterol was 45.1 vs 46.9 mg/dl, LDL-cholesterol was 103.2 vs 102.1 mg/dl, triglycerides were 153.4 vs 148.0 mg/dl, systolic and diastolic blood pressure were respectively 135.3 vs 134.3 and 80.5 vs 79.6 mm/Hg, HbA1c was 7.70 vs 7.67%, and C-reactive Protein was 1.29 vs 1.25 mg/dl, p < .001 for all). The findings were very similar when the analysis was conducted separately for flavonoids or phenolic acids, the two main classes of polyphenols consumed in this population. CONCLUSIONS: Polyphenol intake is associated with a more favorable cardiovascular risk factors profile, independent of major confounders. These findings support the consumption of foods and beverages rich in different classes of polyphenols particularly in people with diabetes. CLINICAL TRIAL: http://www.clinicaltrials.gov; Study ID number: NCT00700856.
2017
Cardiovascular risk; Dietary polyphenols; Flavonoids; Phenolic acids; Type 2 diabetes; Nutrition and Dietetics; Critical Care and Intensive Care Medicine
01 Pubblicazione su rivista::01a Articolo in rivista
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study / Vitale, Marilena; Vaccaro, Olga; Masulli, Maria; Bonora, Enzo; Del Prato, Stefano; Giorda, Carlo B.; Nicolucci, Antonio; Squatrito, Sebastiano; Auciello, Stefania; Babini, Anna C.; Bani, Laura; Buzzetti, Raffaella; Cannarsa, Emanuela; Cignarelli, Mauro; Cigolini, Massimo; Clemente, Gennaro; Cocozza, Sara; Corsi, Laura; D'Angelo, Federica; Dall'Aglio, Elisabetta; Di Cianni, Graziano; Fontana, Lucia; Gregori, Giovanna; Grioni, Sara; Giordano, Carla; Iannarelli, Rossella; Iovine, Ciro; Lapolla, Annunziata; Lauro, Davide; Laviola, Luigi; Mazzucchelli, Chiara; Signorini, Stefano; Tonutti, Laura; Trevisan, Roberto; Zamboni, Chiara; Riccardi, Gabriele; Rivellese, Angela A.. - In: CLINICAL NUTRITION. - ISSN 0261-5614. - 36:6(2017), pp. 1686-1692. [10.1016/j.clnu.2016.11.002]
File allegati a questo prodotto
File Dimensione Formato  
Vitale_Polyphenol_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 600.44 kB
Formato Adobe PDF
600.44 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1025079
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 55
  • ???jsp.display-item.citation.isi??? 46
social impact